N3on's testosterone test result on stream, fact-checked

What did @theclipztv actually say?

The video shows what appears to be a medical professional visiting streamer Neon on a livestream and reviewing his testosterone lab results. The clinician tells him his level is 118 ng/dL, stating the normal range is "between 500 to a thousand nanograms per deciliter" and that Neon should "want to be around 700." The clinician connects his reported fatigue, low motivation, and low libido to that result and names the condition as hypogonadism. They also briefly describe hormonal variability caused by factors like hydration and claim hypogonadism is "pretty common."

The framing is casual and streamed live, which means a medical interpretation of a real lab value was delivered to tens of thousands of viewers in an entertainment context. That matters for how we evaluate the accuracy of what was said.

Does the science back this up?

Mostly yes, but with important caveats. A total testosterone of 118 ng/dL is genuinely low by any clinical standard, and the symptoms described, fatigue, low libido, poor motivation, are textbook hypogonadism criteria. The numbers cited are in the right ballpark but slightly simplified.

The American Urological Association (AUA) defines hypogonadism in men as a total testosterone below 300 ng/dL, confirmed on two morning measurements (Mulhall et al., 2018, Journal of Urology). The Endocrine Society uses a similar threshold of under 300 ng/dL, with a reference range for healthy adult men of roughly 300 to 1000 ng/dL (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism). The clinician's stated lower bound of 500 ng/dL is on the higher end of what most guidelines call "normal," but not fabricated. Some clinicians do use 500 ng/dL as a functional optimization target rather than a diagnostic floor, which is a distinction the video never makes.

At 118 ng/dL, Neon's result falls well below even the most conservative diagnostic threshold. That part is not in dispute.

What did they get wrong (or right)?

They got the core clinical picture right. A level of 118 ng/dL is alarming, the listed symptoms map accurately to hypogonadism, and naming the condition by its clinical term was appropriate. Credit where it's due.

What was sloppy: the clinician said the normal range starts at 500, which overstates the lower bound. Most guidelines set 300 ng/dL as the diagnostic cutoff, not 500. Saying Neon wants "to be around 700" is a reasonable functional target, but presenting it as the baseline normal without context is imprecise. A viewer with, say, 320 ng/dL might walk away thinking they are also severely deficient.

The claim that hormones fluctuate because of "the water you drink" or soap is vague to the point of being unhelpful. There is legitimate research on endocrine-disrupting chemicals in water and personal care products (Meeker, 2010, Reviews on Environmental Health), but framing it the way it was framed here adds confusion, not clarity.

The comment about women's testosterone being "much lower" and varying "case by case" is accurate but under-explained. Normal female total testosterone is generally 15 to 70 ng/dL (Davis et al., 2019, Lancet Diabetes and Endocrinology). That context would have been useful.

What should you actually know?

If you see a result like 118 ng/dL on your own labs, you need a proper clinical workup, not a TikTok clip. Here is what that workup actually looks like.

• Total testosterone should be drawn in the morning (7 to 10 AM) because levels fluctuate diurnally, dropping up to 35% by afternoon (Brambilla et al., 2009, Clinical Endocrinology).
• A single low result is not enough for a diagnosis. Clinical guidelines require two separate low readings before treatment is considered (Mulhall et al., 2018, Journal of Urology).
• Free testosterone and sex hormone-binding globulin (SHBG) levels matter too. A man can have low-normal total testosterone but functionally low free testosterone, which is the biologically active fraction.
• Causes of low testosterone vary widely, including primary hypogonadism (testicular origin), secondary hypogonadism (pituitary or hypothalamic origin), obesity, sleep apnea, and medication side effects. The cause shapes the treatment.
• Hypogonadism prevalence estimates in population studies range from 2% to 38% depending on the threshold used and the population studied (Araujo et al., 2007, Archives of Internal Medicine). Calling it "pretty common" is defensible.

The entertainment framing of a real medical result is the bigger concern here. Lab values mean different things depending on age, time of draw, assay method, and clinical context. None of that was addressed on stream.